The results obtained in our study showed no changes in the expression of BAX. Therefore, it can be concluded that these studies show an ambiguous BAX expression level in patients with ovarian cancer, indicating a variable level of BAX expression in this cancer. Here, BAX is linked to ovarian carcinoma.